(19)
(11) EP 3 638 285 A1

(12)

(43) Date of publication:
22.04.2020 Bulletin 2020/17

(21) Application number: 18733210.1

(22) Date of filing: 14.06.2018
(51) International Patent Classification (IPC): 
A61K 38/16(2006.01)
A61P 25/28(2006.01)
 A61K 45/06(2006.01)
A61K 31/137(2006.01)
(86) International application number:
PCT/EP2018/065893
(87) International publication number:
WO 2018/229230 (20.12.2018 Gazette 2018/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.06.2017 WO PCT/EP2017/064644

(71) Applicants:
  • Universität Ulm
    89081 Ulm (DE)
  • Liss, Birgit
    89081 Ulm (DE)

(72) Inventor:
  • LISS, Birgit
    89081 Ulm (DE)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Dudenstrasse 46
68167 Mannheim
68167 Mannheim (DE)

   


(54) ANTAGONISTS OF CAV2.3 R-TYPE CALCIUM CHANNELS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES